Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study.
Saved in:
| Title: | Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study. |
|---|---|
| Authors: | Zouboulis CC; Departments of Dermatology, Venereology, Allergology, and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane, Dessau, Germany. Electronic address: christos.zouboulis@klinikum-dessau.de., Okun MM; Fort HealthCare, Fort Atkinson, Wisconsin., Prens EP; Department of Dermatology, Erasmus University Medical Centre Rotterdam, Rotterdam, Netherlands., Gniadecki R; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark., Foley PA; Department of Medicine (Dermatology), The University of Melbourne, St Vincent's Hospital Melbourne, and Probity Medical Research, Skin & Cancer Foundation Inc, Melbourne, Australia., Lynde C; The Lynde Centre for Dermatology and Probity Medical Research, Markham, Ontario, Canada., Weisman J; Advanced Medical Research, PC, Atlanta, Georgia., Gu Y; AbbVie Inc, North Chicago, Illinois., Williams DA; AbbVie Inc, North Chicago, Illinois., Jemec GBE; Department of Dermatology, Zealand University Hospital, Health Sciences Faculty, University of Copenhagen, Roskilde, Denmark. |
| Source: | Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2019 Jan; Vol. 80 (1), pp. 60-69.e2. Date of Electronic Publication: 2018 Jun 01. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
